admin • November 2, 2023
George Dooley Memorial

It’s been 24 years – and we will never forget. Twenty-four years without my brother, George, who was also a son, husband, father, teacher, coach and so much more than the roles he played.

George died at the young age of 41 from Hypertrophic Cardiomyopathy (HCM), leaving behind a wife, 2 small children, and family and friends who loved him dearly. It was an incredible shock to everyone. After all, he seemed healthy, was a high school teacher, a coach of several sports, and a young active person. But as we learned, HCM can impact anyone and often go undetected or misdiagnosed.


The Hypertrophic Cardiomyopathy Association (HCMA) has taught us a great deal. This is why we donate a percentage of the profits from our golf outing hosted by The George Dooley Memorial Foundation. George was an avid golfer, and the golf outing is a way to keep George’s legacy alive, raise awareness of HCM, and raise funds for a variety of causes.

How wonderful it was this year to hear that the golf outing was SOLD OUT and we unfortunately had to turn people away. But what an outstanding show of support for George, his family, and for the cause. Now of course we know golfers also come because they love the sport, the event is a lot of fun, and there is food, drink, and great raffle prizes!

So not only do we want to thank the many golfers, sponsors, donors, and volunteers, but we also want to thank HCMA for the important work they do every day. And we know that George, being quite the joker, was looking down upon us all, thinking, “I could have made that shot!” And then – he smiles. -Linda Dooley

HCMA Blog

By Erica Friedman June 26, 2025
Investigative journalists Debbie Cenziper, Megan Rose, Brandon Roberts and Irena Hwang from Pro Publica and NPR have concluded a 14-month long investigation into the quality of generic drugs coming into the United States from overseas. Among the many voices that spoke up for American patients was HCMA Founder and CEO, Lisa Salberg who has felt the effects of low-quality drugs personally. Salberg believes that fixing this problem is something we can do, even in this time, when even health care is highly politicized. Read the key takeaways from ProPublica’s 14-month investigation into the FDA’s oversight of foreign drugmakers in Threat in Your Medicine Cabinet: The FDA’s Gamble on America’s Drugs .
A light blue and dark blue paintbrush stroke intersect to make a stylized
By Erica Friedman June 18, 2025
Alnylam press release on the European Commission approval of AMVUTTRA® (vutrisiran) forwild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM) as an additional indication
Light & dark blue brush stroke that intersect create an abstract letter 'a' next to the word Alnylam
By Erica Friedman June 17, 2025
AMVUTTRA® (vutrisiran) has been approved by the U.S. Food and Drug Administration (FDA) to treat ATTR-CM in adults.
More Posts